274 related articles for article (PubMed ID: 34925369)
21. Integrated longitudinal immunophenotypic, transcriptional and repertoire analyses delineate immune responses in COVID-19 patients.
Notarbartolo S; Ranzani V; Bandera A; Gruarin P; Bevilacqua V; Putignano AR; Gobbini A; Galeota E; Manara C; Bombaci M; Pesce E; Zagato E; Favalli A; Sarnicola ML; Curti S; Crosti M; Martinovic M; Fabbris T; Marini F; Donnici L; Lorenzo M; Mancino M; Ungaro R; Lombardi A; Mangioni D; Muscatello A; Aliberti S; Blasi F; De Feo T; Prati D; Manganaro L; Granucci F; Lanzavecchia A; De Francesco R; Gori A; Grifantini R; Abrignani S
Sci Immunol; 2021 Aug; 6(62):. PubMed ID: 34376481
[TBL] [Abstract][Full Text] [Related]
22. Lymphocyte subset alterations with disease severity, imaging manifestation, and delayed hospitalization in COVID-19 patients.
Wu D; Wu X; Huang J; Rao Q; Zhang Q; Zhang W
BMC Infect Dis; 2021 Jul; 21(1):631. PubMed ID: 34210280
[TBL] [Abstract][Full Text] [Related]
23. T cell immunobiology and cytokine storm of COVID-19.
Luo XH; Zhu Y; Mao J; Du RC
Scand J Immunol; 2021 Mar; 93(3):e12989. PubMed ID: 33113222
[TBL] [Abstract][Full Text] [Related]
24. Characteristics of immune cells and cytokines in patients with coronavirus disease 2019 in Guangzhou, China.
Chen X; Huang J; Huang Y; Chen J; Huang Y; Jiang X; Shi Y
Hum Immunol; 2020 Dec; 81(12):702-708. PubMed ID: 32950268
[TBL] [Abstract][Full Text] [Related]
25. The imbalance between Tregs, Th17 cells and inflammatory cytokines among renal transplant recipients.
Ma L; Zhang H; Hu K; Lv G; Fu Y; Ayana DA; Zhao P; Jiang Y
BMC Immunol; 2015 Sep; 16():56. PubMed ID: 26400627
[TBL] [Abstract][Full Text] [Related]
26. The informative value of CD3+CD4+ and CD3+CD8+ T-cell count and cHIS scale as predictors of severe COVID-19 when using interleukin-6 receptor blockers in the in-hospital setting.
Kruglova TS; Fomina DS
Ter Arkh; 2022 Dec; 94(11):1294-1302. PubMed ID: 37167168
[TBL] [Abstract][Full Text] [Related]
27. Extensive longitudinal immune profiling reveals sustained innate immune activation in COVID-19 patients with unfavorable outcome.
Schrijver B; Assmann JLJC; van Gammeren AJ; Vermeulen RCH; Portengen L; Heukels P; Langerak AW; Dik WA; van der Velden VHJ; Ermens TAAM
Eur Cytokine Netw; 2020 Dec; 31(4):154-167. PubMed ID: 33648924
[TBL] [Abstract][Full Text] [Related]
28. Identification of SARS-CoV-2-specific immune alterations in acutely ill patients.
Rébillard RM; Charabati M; Grasmuck C; Filali-Mouhim A; Tastet O; Brassard N; Daigneault A; Bourbonnière L; Anand SP; Balthazard R; Beaudoin-Bussières G; Gasser R; Benlarbi M; Moratalla AC; Solorio YC; Boutin M; Farzam-Kia N; Descôteaux-Dinelle J; Fournier AP; Gowing E; Laumaea A; Jamann H; Lahav B; Goyette G; Lemaître F; Mamane VH; Prévost J; Richard J; Thai K; Cailhier JF; Chomont N; Finzi A; Chassé M; Durand M; Arbour N; Kaufmann DE; Prat A; Larochelle C
J Clin Invest; 2021 Apr; 131(8):. PubMed ID: 33635833
[TBL] [Abstract][Full Text] [Related]
29. Elevated levels of circulating CD4(+) CRTh2(+) T cells characterize severe asthma.
Palikhe NS; Laratta C; Nahirney D; Vethanayagam D; Bhutani M; Vliagoftis H; Cameron L
Clin Exp Allergy; 2016 Jun; 46(6):825-36. PubMed ID: 27079298
[TBL] [Abstract][Full Text] [Related]
30. Negative Clinical Evolution in COVID-19 Patients Is Frequently Accompanied With an Increased Proportion of Undifferentiated Th Cells and a Strong Underrepresentation of the Th1 Subset.
Gutiérrez-Bautista JF; Rodriguez-Nicolas A; Rosales-Castillo A; Jiménez P; Garrido F; Anderson P; Ruiz-Cabello F; López-Ruz MÁ
Front Immunol; 2020; 11():596553. PubMed ID: 33324414
[TBL] [Abstract][Full Text] [Related]
31. Circulating cell-free DNA, peripheral lymphocyte subsets alterations and neutrophil lymphocyte ratio in assessment of COVID-19 severity.
Hammad R; Eldosoky MAER; Fouad SH; Elgendy A; Tawfeik AM; Alboraie M; Abdelmaksoud MF
Innate Immun; 2021 Apr; 27(3):240-250. PubMed ID: 33646058
[TBL] [Abstract][Full Text] [Related]
32. Differential expression of lymphocyte subpopulations in the peripheral blood of patients with COVID-19: Implications for disease severity and prognosis.
Xu X; Huang J; Zhang H; Lu W; Liu J
Immun Inflamm Dis; 2024 May; 12(5):e1281. PubMed ID: 38780019
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of simple and cost-effective immuno- haematological markers to predict outcome in hospitalized severe COVID-19 patients, with a focus on diabetes mellitus - A retrospective study in Andhra Pradesh, India.
Ramesh J; Reddy SLS; Rajesh M; Varghese J
Diabetes Metab Syndr; 2021; 15(3):739-745. PubMed ID: 33819728
[TBL] [Abstract][Full Text] [Related]
34. Asymptomatic and Mild SARS-CoV-2 Infections Elicit Lower Immune Activation and Higher Specific Neutralizing Antibodies in Children Than in Adults.
Petrara MR; Bonfante F; Costenaro P; Cantarutti A; Carmona F; Ruffoni E; Di Chiara C; Zanchetta M; Barzon L; Donà D; Da Dalt L; Bortolami A; Pagliari M; Plebani M; Rossi P; Cotugno N; Palma P; Giaquinto C; De Rossi A
Front Immunol; 2021; 12():741796. PubMed ID: 34659235
[TBL] [Abstract][Full Text] [Related]
35. Immunological Biomarkers of COVID-19.
Lei R; Mohan C
Crit Rev Immunol; 2020; 40(6):497-512. PubMed ID: 33900694
[TBL] [Abstract][Full Text] [Related]
36. [Evaluation of clinical value of Xuebijing combined with human immunoglobulin in severe and critically ill patients with coronavirus disease 2019].
Chen L; Zhang A; Li Q; Cui Y; Yuan G
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2021 Apr; 33(4):399-404. PubMed ID: 34053480
[TBL] [Abstract][Full Text] [Related]
37. T cell counts and IL-6 concentration in blood of North African COVID-19 patients are two independent prognostic factors for severe disease and death.
Belaid B; Lamara Mahammad L; Mihi B; Rahali SY; Djidjeli A; Larab Z; Berkani L; Berkane I; Sayah W; Merah F; Lazli NZ; Kheddouci L; Kadi A; Ouali M; Khellafi R; Mekideche D; Kheliouen A; Ayoub S; Hamidi RM; Derrar F; Gharnaout M; Allam I; Djidjik R
J Leukoc Biol; 2022 Jan; 111(1):269-281. PubMed ID: 33527487
[TBL] [Abstract][Full Text] [Related]
38. Blood Interferon-α Levels and Severity, Outcomes, and Inflammatory Profiles in Hospitalized COVID-19 Patients.
Contoli M; Papi A; Tomassetti L; Rizzo P; Vieceli Dalla Sega F; Fortini F; Torsani F; Morandi L; Ronzoni L; Zucchetti O; Pavasini R; Fogagnolo A; Volta CA; Bartlett NW; Johnston SL; Spadaro S; Campo G
Front Immunol; 2021; 12():648004. PubMed ID: 33767713
[No Abstract] [Full Text] [Related]
39. Lymphocyte subsets with the lowest decline at baseline and the slow lowest rise during recovery in COVID-19 critical illness patients with diabetes mellitus.
Liu D; Lan L; Luo D; Zhao B; Wei G; He Y; Zhang R; Liu Y
Diabetes Res Clin Pract; 2020 Sep; 167():108341. PubMed ID: 32707212
[TBL] [Abstract][Full Text] [Related]
40. Dynamics of cytokines and lymphocyte subsets associated with the poor prognosis of severe COVID-19.
Li Q; Xu W; Li WX; Huang CL; Chen L
Eur Rev Med Pharmacol Sci; 2020 Dec; 24(23):12536-12544. PubMed ID: 33336774
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
